Medline MDLN
NASDAQ MDLN
$34.05 -0.64 (-1.84%)
As of: Sep 9, 2026 · 3:59 PM EDT

Medline (MDLN) Net Margin (2025 - 2026)

Medline's (MDLN) quarterly Net Margin came in at 1.81% in Q2 2026, down 303.0% year-over-year from 0.89% in Q2 2025, and down 44.36% quarter-over-quarter from 3.25% in Q1 2026.

Analysis

Medline (MDLN) Net Margin (2025 - 2026) Analysis & Trends

Medline (MDLN) has reported Net Margin for 2 consecutive years, with 1.81% the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Net Margin fell 303.0% year-over-year to 1.81% in Q2 2026; TTM through Jun 2026 was 3.62%, a N/A change from a year earlier, with the FY2025 full-year figure at 4.07%, down 64.0% from the prior year.
  • Net Margin was 1.81% for Q2 2026 at Medline, down from 3.25% in the prior quarter.
  • Over five years, Net Margin peaked at 4.85% in Q1 2025 and troughed at 1.81% in Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Becton Dickinson 49.48 Bn 48.62 Bn 2.32 Bn 7.59%
2 Medline 29.24 Bn 26.56 Bn 2.22 Bn 1.81%
3 West Pharmaceutical Services 23.94 Bn 23.51 Bn 329.20 Mn 16.96%
4 Baxter International 12.66 Bn 10.51 Bn 1.03 Bn 4.26%
5 Stevanato Group S.p.A 5.51 Bn 5.40 Bn 100.91 Mn 7.60%
6 Acme United 233.67 Mn 228.63 Mn 26.69 Mn 8.05%
7 Rockwell Medical 31.87 Mn 7.07 Mn 3.24 Mn -7.32%
8 Retractable Technologies 21.39 Mn -18.48 Mn 190,852.00 38.51%
9 United Health Products 9.09 Mn 9.06 Mn - -
10 Cuprina Holdings (Cayman) 7.45 Mn 4.33 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 1.81%
Mar 28, 2026 3.25%
Jun 28, 2025 4.84%
Mar 29, 2025 4.85%